Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 10, 2005, Pages 839-844

  Skilton, Michael R ^b   Nakhla, Shirley ^c   Sieveking, Daniel P ^c   Caterson, Ian D ^b   Celermajer, David S ^a,b,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Cell adhesion molecules; Cytokines

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GHRELIN; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; PEPTIDE; RESISTIN; VASCULAR CELL ADHESION MOLECULE 1; PEPTIDE HORMONE;

ANOREXIA NERVOSA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOMATION; CELL ADHESION; CELL COUNT; CELL GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRADER WILLI SYNDROME; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; TIME;

CELL ADHESION; CELL ADHESION MOLECULES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INSULIN; INTERCELLULAR ADHESION MOLECULE-1; LEPTIN; MONOCYTES; PEPTIDE HORMONES; RESISTIN; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33644668189     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04274.x     Document Type: Article

References (45)

1. Kopelman PG. Obesity as a medical problem. Nature 2000 404 : 635 43.
2. Seidell JC. Obesity, insulin resistance and diabetes: A worldwide epidemic. Br. J. Nutr. 2000 83 ( Suppl. 1 S5 8.
3. Rabkin SW Mathewson FA Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: The Manitoba Study. Am. J. Cardiol. 1977 39 : 452 8.
4. Eckel RH Krauss RM. American Heart Association call to action: Obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation 1998 97 : 2099 100.
5. Cooke JP Oka RK. Does leptin cause vascular disease? Circulation 2002 106 : 1904 5.
6. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993 362 : 801 9.
7. McCrohon JA Jessup W Handelsman DJ Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation 1999 99 : 2317 22.
8. Minter AJ Dawes J Chesterman CN. Effects of heparin and endothelial cell growth supplement on haemostatic functions of vascular endothelium. Thromb. Haemost. 1992 67 : 718 23.
9. Garner B Dean RT Jessup W. Human macrophage-mediated oxidation of low-density lipoprotein is delayed and independent of superoxide production. Biochem. J. 1994 301 : 421 8.
10. Shiiya T Nakazato M Mizuta M et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J. Clin. Endocrinol. Metab. 2002 87 : 240 4.
11. Tschop M Weyer C Tataranni PA Devanarayan V Ravussin E Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001 50 : 707 9.
12. Haqq AM Farooqi IS O'Rahilly S et al. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2003 88 : 174 8.
13. Otto B Cuntz U Fruehauf E et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur. J. Endocrinol. 2001 145 : 669 73.
14. Yannakoulia M Yiannakouris N Bluher S Matalas AL Klimis-Zacas D Mantzoros CS. Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J. Clin. Endocrinol. Metab. 2003 88 : 1730 6.
15. Fujinami A Obayashi H Ohta K et al. Enzyme-linked immunosorbent assay for circulating human resistin: Resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta 2004 339 : 57 63.
16. Fehmann HC Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm. Metab. Res. 2002 34 : 671 3.
17. Zhang JL Qin YW Zheng X Qiu JL Zou DJ. Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet. Med. 2003 20 : 828 31.
18. Cummings DE Weigle DS Frayo RS et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N. Engl. J. Med. 2002 346 : 1623 30.
19. Nedvidkova J Krykorkova I Bartak V et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 2003 88 : 1678 82.
20. Garcia-Rubira JC Hidalgo R Gomez-Barrado JJ Romero D Cruz Fernandez JM. Anorexia nervosa and myocardial infarction. Int. J. Cardiol. 1994 45 : 138 40.
21. DelParigi A Tschop M Heiman ML et al. High circulating ghrelin: A potential cause for hyperphagia and obesity in Prader-Willi syndrome. J. Clin. Endocrinol. Metab. 2002 87 : 5461 4.
22. Smith A Loughnan G Steinbeck K. Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy. J. Med. Genet. 2003 40 : E63.
23. Howard AD Feighner SD Cully DF et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996 273 : 974 7.
24. Kojima M Hosoda H Date Y Nakazato M Matsuo H Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 : 656 60.
25. Gnanapavan S Kola B Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002 87 : 2988.
26. 125I-His (9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: Up-regulation of receptors with athersclerosis. Br. J. Pharmacol. 2001 134 : 143 9.
27. Okumura H Nagaya N Enomoto M Nakagawa E Oya H Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol. 2002 39 : 779 83.
28. Li WG Gavrila D Liu X et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004 109 : 2221 6.
29. Verma S Li SH Wang CH et al. Resistin promotes endothelial cell activation: Further evidence of adipokine-endothelial interaction. Circulation 2003 108 : 736 40.
30. Kawanami D Maemura K Takeda N et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: A new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 2004 314 : 415 19.
31. Zhang J Qin Y Zheng X et al. [The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure]. Zhonghua Yi Xue Za Zhi 2002 82 : 1609 12 (in Chinese).
32. Stejskal D Adamovska S Bartek J Jurakova R Proskova J. Resistin: Concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 2003 147 : 63 9.
33. Heilbronn LK Rood J Janderova L et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 2004 89 : 1844 8.
34. Youn BS Yu KY Park HJ et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2004 89 : 150 6.
35. Lembo G Vecchione C Fratta L et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000 49 : 293 7.
36. Nakagawa K Higashi Y Sasaki S Oshima T Matsuura H Chayama K. Leptin causes vasodilation in humans. Hypertens. Res. 2002 25 : 161 5.
37. Laakso M Edelman SV Brechtel G Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J. Clin. Invest. 1990 85 : 1844 52.
38. Quehenberger P Exner M Sunder-Plassmann R et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ. Res. 2002 90 : 711 18.
39. Parhami F Tintut Y Ballard A Fogelman AM Demer LL. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin. Circ. Res. 2001 88 : 954 60.
40. Maruyama I Nakata M Yamaji K. Effect of leptin in platelet and endothelial cells. Obesity and arterial thrombosis. Ann. N.Y. Acad. Sci. 2000 902 : 315 19.
41. Konstantinides S Schafer K Loskutoff DJ. The prothrombotic effects of leptin possible implications for the risk of cardiovascular disease in obesity. Ann. N.Y. Acad. Sci. 2001 947 : 134 41.
42. Madonna R Pandolfi A Massaro M Consoli A De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 2004 47 : 532 6.
43. De Mattia G Bravi MC Costanzo A et al. Effects of insulin on in vitro vascular cell adhesion molecule-1 expression and in vivo soluble VCAM-1 release. Diabetologia 1999 42 : 1235 9.
44. Langenfeld MR Nakhla S Death AK Jessup W Celermajer DS. Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clin. Sci. 2001 101 : 731 8.
45. Ouchi N Kihara S Arita Y et al. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999 100 : 2473 6.